Showing results (31-40 of 108) with videos related to

Sort By:
Pageof 11
Drug Safety|June 27, 2019
Androgen Deprivation Therapy for Prostate Cancer and the Risk of Rheumatoid Arthritis: A Population-Based Cohort StudyAdi J Klil-Drori, Christina Santella, Koray Tascilar, et al.
American Journal of Epidemiology|June 9, 2016
Androgen Deprivation Therapy and the Incidence of Inflammatory Bowel Disease in Patients With Prostate CancerAdi J Klil-Drori, Koray Tascilar, Hui Yin, et al.
Journal of Medical Economics|May 21, 2025
Cost-effectiveness of enzalutamide with androgen-deprivation therapy (ADT) versus ADT alone for the treatment of high-risk biochemically recurrent non-metastatic castration-sensitive prostate cancer in CanadaArmen Aprikian, Fred Saad, Ewa Wywial, et al.
Practical Radiation Oncology|September 16, 2021
Stereotactic Ablative Radiation Therapy for the Treatment of Upper Urinary Tract Urothelial CarcinomaJulia Khriguian, Horacio Patrocinio, Sero Andonian, et al.
Human Pathology|September 4, 2012
Prognostic factors in T1 bladder urothelial carcinoma: the value of recording millimetric depth of invasion, diameter of invasive carcinoma, and muscularis mucosa invasionFadi Brimo, Chenbo Wu, Nebras Zeizafoun, et al.
Cancer|August 19, 2004
Up-regulation of Wnt-1 and beta-catenin production in patients with advanced metastatic prostate carcinoma: potential pathogenetic and prognostic implicationsGaoping Chen, Nicholas Shukeir, Anil Potti, et al.
BMC Public Health|September 20, 2015
Metabolic syndrome and prostate cancer risk in a population-based case-control study in Montreal, CanadaAudrey Blanc-Lapierre, Andrea Spence, Pierre I Karakiewicz, et al.
Case Reports in Anesthesiology|January 3, 2024
Migration of an Inferior Vena Cava Tumor Thrombus during Renal Cell Carcinoma ResectionRoupen Hatzakorzian, Andrea Blotsky, Albert Moore, et al.
Mutation Research|August 17, 2011
Mitochondrial DNA damage is sensitive to exogenous H(2)O(2) but independent of cellular ROS production in prostate cancer cellsSam W Chan, Phuong-Nam Nguyen, David Ayele, et al.
European Urology|December 15, 2010
A panel of TMPRSS2:ERG fusion transcript markers for urine-based prostate cancer detection with high specificity and sensitivityPhuong-Nam Nguyen, Philippe Violette, Sam Chan, et al.
Pageof 11